469 results on '"Kicic, Anthony"'
Search Results
2. Phage therapy could be key to conquering persistent bacterial lung infections in children
Catalog
Books, media, physical & digital resources
3. Real world effectiveness of early ensitrelvir treatment in patients with SARS-CoV-2, a retrospective case series
4. Real time monitoring of respiratory viral infections in cohort studies using a smartphone app
5. The respiratory health effects of acute in vivo diesel and biodiesel exhaust in a mouse model
6. Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial
7. Exploring indoor and outdoor dust as a potential tool for detection and monitoring of COVID-19 transmission
8. Ca-EDTA restores the activity of ceftazidime-avibactam or aztreonam against carbapenemase-producing Klebsiella pneumoniae infections
9. COVID-19 monitoring with sparse sampling of sewered and non-sewered wastewater in urban and rural communities
10. Biodiesel feedstock determines exhaust toxicity in 20% biodiesel: 80% mineral diesel blends
11. Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway disease
12. Phage therapy to treat cystic fibrosis Burkholderia cepacia complex lung infections: perspectives and challenges.
13. High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy
14. Airway epithelium respiratory illnesses and allergy (AERIAL) birth cohort: study protocol
15. Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial
16. Changes in airway inflammation with pseudomonas eradication in early cystic fibrosis
17. Ivacaftor or lumacaftor/ivacaftor treatment does not alter the core CF airway epithelial gene response to rhinovirus
18. Community-based mpox and sexually transmitted disease surveillance using discarded condoms in the global south [Correspondence]
19. Wastewater-based epidemiological surveillance of SARS-CoV-2 new variants BA.2.86 and offspring JN.1 in south and Southeast Asia
20. Airway epithelium respiratory illnesses and allergy (AERIAL) birth cohort: Study protocol
21. Increased faecal shedding in SARS-CoV-2 variants BA.2.86 and JN.1 [Correspondence]
22. Transcriptomic analysis of primary nasal epithelial cells reveals altered interferon signalling in preterm birth survivors at one year of age.
23. Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis
24. Exploring the Complexity of the Human Respiratory Virome through an In Silico Analysis of Shotgun Metagenomic Data Retrieved from Public Repositories.
25. Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis
26. Stability Considerations for Bacteriophages in Liquid Formulations Designed for Nebulization
27. The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways
28. Defining the pediatric response to SARS-CoV-2 variants
29. Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes?
30. Terminal Deuterium Atoms Protect Silicon from Oxidation
31. Tracing the new SARS-CoV-2 variant BA.2.86 in the community through wastewater surveillance in Bangkok, Thailand
32. Tracing the transmission of mpox through wastewater surveillance in Southeast Asia
33. Respiratory Health Effects of In Vivo Sub-Chronic Diesel and Biodiesel Exhaust Exposure
34. Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection
35. Respiratory Health Effects of In Vivo Sub-Chronic Diesel and Biodiesel Exhaust Exposure
36. Phage Therapy as an Alternative Treatment Modality for Resistant Staphylococcus aureus Infections
37. Bacteriophage: A new therapeutic player to combat neutrophilic inflammation in chronic airway diseases
38. WS1.7: HAVING THE RIGHT CHEMISTRY: EFFECT OF BACTERIOPHAGE, ANTIBIOTICS AND ADJUVANT ON PSEUDOMONAS AERUGINOSA
39. Living with lung disease: experimental models to assess the long-term effects of prematurity
40. Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells
41. Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells
42. Toxicity of different biodiesel exhausts in primary human airway epithelial cells grown at air-liquid interface
43. AI-Driven Cell Tracking to Enable High-Throughput Drug Screening Targeting Airway Epithelial Repair for Children with Asthma
44. Investigating the Implications of CFTR Exon Skipping Using a Cftr Exon 9 Deleted Mouse Model
45. SLC6A14 Impacts Cystic Fibrosis Lung Disease Severity via mTOR and Epithelial Repair Modulation
46. Primary Nasal Epithelial Cells as a Surrogate Cell Culture Model for Type-II Alveolar Cells to Study ABCA-3 Deficiency
47. Alpha-1 Antitrypsin Mitigates the Inhibition of Airway Epithelial Cell Repair by Neutrophil Elastase
48. Dysregulated Notch Signaling in the Airway Epithelium of Children with Wheeze
49. Viral Induced Effects on a Vulnerable Epithelium; Lessons Learned From Paediatric Asthma and Eosinophilic Oesophagitis
50. 1073. Sulbactam-Durlobactam Has Potent Activity Against Multidrug-Resistant Acinetobacter baumannii Clinical Isolates From Thai Patients With Chronic Infections
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.